The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Quest for Novel Chemical Entities through Incorporation of Silicon in Drug Scaffolds
Open accessAbstract
In order to optimize a lead molecule for further development, bioisosteric replacements are generally adopted as one of the strategies. Silicon appears to be the right choice as a carbon isostere because of the similarity in chemical properties. Silicon can be strategically introduced in a molecule to modulate its druglike properties, providing medicinal chemists with an unconventional strategy for replacing a carbon atom. Silicon can also be introduced to replace other heteroatoms and can act as a surrogate of functional groups such as olefin and amide as well. The present Perspective focuses on the opportunities that silicon incorporation offers in drug discovery, with an emphasis on case studies where introduction of silicon has created a benefit over its analog. We have tried to highlight all the recent developments in the field and briefly discuss the challenges associated with them.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
Alzheimer's Disease: A Disorder of Cortical Cholinergic Innervation
Coyle, J. T., Price, D. L., & DeLong, M. R. (1983) · Science · doi:10.1126/science.6338589 · Cited by 3,052
Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
Meanwell, N. A. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm1013693 · Cited by 2,854
Targeting proteases: successes, failures and future prospects
Turk, B. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2092 · Cited by 1,363
Bioisosterism: A Rational Approach in Drug Design
Patani, G. A., & LaVoie, E. J. (1996) · Chemical Reviews · doi:10.1021/cr950066q · Cited by 1,328
Organosilicon Molecules with Medicinal Applications
Franz, A. K., & Wilson, S. O. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm3010114 · Cited by 1,151
Clayden, J., Greeves, N., & Warren, S. (2012) · Oxford University Press eBooks · doi:10.1093/hesc/9780199270293.001.0001 · Cited by 942
Approaches to transport therapeutic drugs across the blood–brain barrier to treat brain diseases
Gabathuler, R. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.028 · Cited by 802
Role of Pharmacokinetics and Metabolism in Drug Discovery and Development
Lin, J. H., & Lu, A. Y. H. (1997) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01340-1 · Cited by 708
Bioisosterism: A Useful Strategy for Molecular Modification and Drug Design
Lima, L., & Barreiro, E. (2005) · Current Medicinal Chemistry · doi:10.2174/0929867053363540 · Cited by 672
Unusual Amino Acids in Medicinal Chemistry
Blaskovich, M. A. T. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00319 · Cited by 635
Medicinal Chemistry of Combretastatin A4: Present and Future Directions
Tron, G. C., Pirali, T., Sorba, G., Pagliai, F., Busacca, S., & Genazzani, A. A. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0512903 · Cited by 629
Directed evolution of cytochrome c for carbon–silicon bond formation: Bringing silicon to life
Kan, S. B. J., Lewis, R. D., Chen, K., & Arnold, F. H. (2016) · Science · doi:10.1126/science.aah6219 · Cited by 579
Current status of phthalocyanines in the photodynamic therapy of cancer
ALLEN, C. M., SHARMAN, W. M., & VAN LIER, J. E. (2001) · Journal of Porphyrins and Phthalocyanines · doi:10.1002/jpp.324 · Cited by 550
Photodynamic Therapy and the Development of Metal-Based Photosensitisers
Josefsen, L. B., & Boyle, R. W. (2008) · Metal-Based Drugs · doi:10.1155/2008/276109 · Cited by 536
Cancer Therapies Utilizing the Camptothecins: A Review of the in Vivo Literature
Venditto, V. J., & Simanek, E. E. (2010) · Molecular Pharmaceutics · doi:10.1021/mp900243b · Cited by 452
Blood–brain barrier shuttle peptides: an emerging paradigm for brain delivery
Oller-Salvia, B., Sánchez-Navarro, M., Giralt, E., & Teixidó, M. (2016) · Chemical Society Reviews · doi:10.1039/c6cs00076b · Cited by 442
The inhibitors of apoptosis: there is more to life than Bcl2
Liston, P., Fong, W. G., & Korneluk, R. G. (2003) · Oncogene · doi:10.1038/sj.onc.1207101 · Cited by 440
Chemistry challenges in lead optimization: silicon isosteres in drug discovery
Showell, G. A., & Mills, J. S. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02726-0 · Cited by 427
Dufaud, V., & Basset, J. (1998) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19980403)37:6<812::aid-anie812>3.0.co;2-i · Cited by 282
Progress in the Medicinal Chemistry of Silicon: C/Si Exchange and Beyond
Fujii, S., & Hashimoto, Y. (2017) · Future Medicinal Chemistry · doi:10.4155/fmc-2016-0193 · Cited by 210
NEW PHTHALOCYANINE PHOTOSENSITIZERS FOR PHOTODYNAMIC THERAPY
Oleinick, N. L., Antunez, A. R., Clay, M. E., Rihter, B. D., & Kenney, M. E. (1993) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1993.tb02282.x · Cited by 208
Mutahi, M. W., Nittoli, T., Guo, L., & Sieburth, S. M. (2002) · Journal of the American Chemical Society · doi:10.1021/ja026158w · Cited by 196
Synthesis and Cellular Profiling of Diverse Organosilicon Small Molecules
Franz, A. K., Dreyfuss, P. D., & Schreiber, S. L. (2007) · Journal of the American Chemical Society · doi:10.1021/ja067552n · Cited by 196
Gately, S., & West, R. (2007) · Drug Development Research · doi:10.1002/ddr.20177 · Cited by 178
Exploitation of silicon medicinal chemistry in drug discovery
MILLS, J. S., & Showell, G. A. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.9.1149 · Cited by 157
Baron, E. D., Malbasa, C. L., Santo‐Domingo, D., Fu, P., Miller, J. D., Hanneman, K. K., Hsia, A. H., Oleinick, N. L., Colussi, V., & Cooper, K. D. (2010) · Lasers in Surgery and Medicine · doi:10.1002/lsm.20984 · Cited by 154
Silanediol Protease Inhibitors: From Conception to Validation
Sieburth, S. M., & Chen, C. (2005) · European Journal of Organic Chemistry · doi:10.1002/ejoc.200500508 · Cited by 150
Identification of a potentially neurotoxic pyridinium metabolite of haloperidol in rats
Subramanyam, B., Rollema, H., Woolf, T. F., & Castagnoli, N. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)91936-m · Cited by 131
Fujii, S., Miyajima, Y., Masuno, H., & Kagechika, H. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3013757 · Cited by 130
Stevenazzi, A., Marchini, M., Sandrone, G., Vergani, B., & Lattanzio, M. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.10.016 · Cited by 119
Tacke, R., Popp, F., Müller, B., Theis, B., Burschka, C., Hamacher, A., Kassack, M. U., Schepmann, D., Wünsch, B., Jurva, U., et al. (2007) · ChemMedChem · doi:10.1002/cmdc.200700205 · Cited by 104
Kim, Y.-M., Farrah, S. R., & Baney, R. H. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.08.036 · Cited by 97
Pujals, S., Fernández‐Carneado, J., Kogan, M. J., Martínez, J., Cavelier, F., & Giralt, E. (2006) · Journal of the American Chemical Society · doi:10.1021/ja060036c · Cited by 91
New highly lipophilic camptothecin BNP1350 is an effective drug in experimental human cancer
van Hattum, A. H., Pinedo, H. M., Schlüper, H. M. M., Hausheer, F. H., & Boven, E. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20001015)88:2<260::aid-ijc18>3.0.co;2-q · Cited by 86
Chen, C.-A., Sieburth, S. M., Glekas, A., Hewitt, G. W., Trainor, G. L., Erickson‐Viitanen, S., Garber, S., Cordova, B. C., Jeffry, S., & Klabe, R. M. (2001) · Chemistry & Biology · doi:10.1016/s1074-5521(01)00079-5 · Cited by 86
Ramesh, R., Shingare, R. D., Kumar, V. D., Anand, A., Swetha, B. V., Veeraraghavan, S., Viswanadha, S., Ummanni, R., Gokhale, R. S., & Reddy, D. S. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.07.009 · Cited by 85
Self-citationJohansson, T., Weidolf, L. O. G., Popp, F., Tacke, R., & Jurva, U. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.028449 · Cited by 75
Designing Irreversible Inhibitors—Worth the Effort?
González‐Bello, C. (2016) · ChemMedChem · doi:10.1002/cmdc.201500469 · Cited by 74
The Effect of Various Zinc Binding Groups on Inhibition of Histone Deacetylases 1–11
Madsen, A. S., Kristensen, H. M. E., Lanz, G., & Olsen, C. A. (2013) · ChemMedChem · doi:10.1002/cmdc.201300433 · Cited by 74
Cell Death Pathways and Phthalocyanine as an Efficient Agent for Photodynamic Cancer Therapy
Mfouo-Tynga, I. S., & Abrahamse, H. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160510228 · Cited by 70
Structure-based design of substituted hexafluoroisopropanol-arylsulfonamides as modulators of RORc
Fauber, B. P., Boenig, G. D. L., Burton, B., Eidenschenk, C., Everett, C., Gobbi, A., Hymowitz, S. G., Johnson, A. R., Liimatta, M. B., Lockey, P. M., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.10.054 · Cited by 66
Doszczak, L., Kraft, P., Weber, H., Bertermann, R., Triller, A., Hatt, H. H., & Tacke, R. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200605002 · Cited by 65
Seetharamsingh, B., Ramesh, R., Dange, S. S., Khairnar, P. V., Singhal, S., Upadhyay, D. J., Veeraraghavan, S., Viswanadha, S., Vakkalanka, S. V. S., & Reddy, D. S. (2015) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5b00213 · Cited by 59
Self-citationSerine Protease Inhibition by a Silanediol Peptidomimetic
Singh, S., & Sieburth, S. M. (2012) · Organic Letters · doi:10.1021/ol301933n · Cited by 57
(R)-Sila-venlafaxine: A selective noradrenaline reuptake inhibitor for the treatment of emesis
Showell, G. A., Barnes, M. J., Daiss, J. O., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.12.062 · Cited by 57
Silicon Incorporated Morpholine Antifungals: Design, Synthesis, and Biological Evaluation
Jachak, G. R., Ramesh, R., Sant, D. G., Jorwekar, S. U., Jadhav, M. R., Tupe, S. G., Deshpande, M. V., & Reddy, D. S. (2015) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5b00245 · Cited by 52
Self-citationJuers, D. H., Kim, J. C., Matthews, B. W., & Sieburth, S. M. (2005) · Biochemistry · doi:10.1021/bi051346v · Cited by 52
Reddy, G. D., Park, S., Cho, H. M., Kim, T., & Lee, M. E. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300421h · Cited by 51
Silicon Analogues of the RXR‐Selective Retinoid Agonist SR11237 (BMS649): Chemistry and Biology
Lippert, W. P., Burschka, C., Götz, K., Kaupp, M., Ivanova, D. I., Gaudon, C., Sato, Y., Antony, P., Rochel, N., Moras, D., et al. (2009) · ChemMedChem · doi:10.1002/cmdc.200900090 · Cited by 49
Zaidi, S. I. A., Agarwal, R., Eichler, G., Rihter, B. D., Kenney, M. E., & Mukhtar, H. (1993) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1993.tb09550.x · Cited by 48
Morris, R. L., Varnes, M. E., Kenney, M. E., Li, Y.-S., Azizuddin, K., McEnery, M. W., & Oleinick, N. L. (2002) · Photochemistry and Photobiology · doi:10.1562/0031-8655(2002)0750652tpbrip2.0.co2 · Cited by 46
van Hattum, A. H., Schlüper, H. M. M., Hausheer, F. H., et al. (2002) · International Journal of Cancer · doi:10.1002/ijc.10434 · Cited by 43
Geyer, M., Wellner, E., Jurva, U., Saloman, S., Armstrong, D., & Tacke, R. (2015) · ChemMedChem · doi:10.1002/cmdc.201500040 · Cited by 43
Nakamura, M., Kajita, D., Matsumoto, Y., & Hashimoto, Y. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.09.046 · Cited by 41
Hu, Y., Wang, Y., Fang, L., Ma, C., & Wang, J. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.04.038 · Cited by 35
Madsen, J. L. H., Andersen, T. L., Santamaria, S., Nagase, H., Enghild, J. J., & Skrydstrup, T. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301000k · Cited by 32
Tacke, R., Müller, V., Büttner, M. W., Lippert, W. P., Bertermann, R., Daiss, J. O., Khanwalkar, H., Furst, A., Gaudon, C., & Gronemeyer, H. (2009) · ChemMedChem · doi:10.1002/cmdc.200900257 · Cited by 29
Arnold, S. M., Rinehart, J. J., Tsakalozou, E., Eckardt, J. R., Fields, S. Z., Shelton, B. J., DeSimone, P. A., Kee, B. K., Moscow, J. A., & Leggas, M. L. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2429 · Cited by 29
Effect of MDL 73,745 on acetylcholine and biogenic amine levels in rat cortex
Zhu, X., Giacobini, E., & Hornsperger, J. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00014-c · Cited by 27
Madsen, J. L. H., Hjørringgaard, C. U., Vad, B. S., Otzen, D. E., & Skrydstrup, T. (2016) · Chemistry - A European Journal · doi:10.1002/chem.201600445 · Cited by 27
Acetylcholinesterase inhibition by zifrosilone: Pharmacokinetics and pharmacodynamics*
Cutler, N. R., Seifert, R. D., Schleman, M. M., Sramek, J. J., Szylleyko, O. J., Howard, D. R., Barchowsky, A., Wardle, T. S., & Brass, E. P. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90072-1 · Cited by 26
Kajita, D., Nakamura, M., Matsumoto, Y., Ishikawa, M., Hashimoto, Y., & Fujii, S. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.05.045 · Cited by 23
Tacke, R., Bertermann, R., Burschka, C., Dorrich, S., Fischer, M., Müller, B., Meyerhans, G., Schepmann, D., Wünsch, B., Árnason, I., et al. (2011) · ChemMedChem · doi:10.1002/cmdc.201100423 · Cited by 23
Ramesh, R., & Reddy, D. S. (2014) · Organic & Biomolecular Chemistry · doi:10.1039/c4ob00294f · Cited by 23
Self-citationStereoselective and improved syntheses and anticancer testing of 3′-O-silatranylthymidines
Black, C. A., Ucci, J. W., Vorpagel, J. S., Mauck, M. C., & Fenlon, E. E. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00820-x · Cited by 22
Nakamura, M., Makishima, M., & Hashimoto, Y. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.01.060 · Cited by 21
Lopez-Barcons, L. A., Zhang, J., Sidwitayawan, G., Burke, T. G., & Perez-Soler, R. (2004) · Neoplasia · doi:10.1593/neo.04139 · Cited by 20
Synthesis and Pharmacological Properties of Silicon‐Containing GPR81 and GPR109A Agonists
Geyer, M., Baus, J. A., Fjellström, O., Wellner, E., Gustafsson, L., & Tacke, R. (2015) · ChemMedChem · doi:10.1002/cmdc.201500343 · Cited by 15
Shelton, J. R., Cutler, C. E., Browning, M. S., Balzarini, J. M., & Peterson, M. A. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.08.050 · Cited by 15
Zablotskaya, A., Segal, I., Popelis, Y., Grı̄nberga, S., Shestakova, I., Nikolajeva, V., & Eze, D. (2012) · Applied Organometallic Chemistry · doi:10.1002/aoc.2952 · Cited by 15
Shelton, J. R., Cutler, C. E., Oliveira, M. D. M., Balzarini, J. M., & Peterson, M. A. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.11.043 · Cited by 14
Svennebring, A. M. (2015) · Journal of Applied Toxicology · doi:10.1002/jat.3248 · Cited by 5
Cited by
Amide Bond Bioisosteres: Strategies, Synthesis, and Successes
Kumari, S., Carmona, A. V., Tiwari, A. K., & Trippier, P. C. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00530 · Cited by 654
Selective Arene Hydrogenation for Direct Access to Saturated Carbo‐ and Heterocycles
Wiesenfeldt, M. P., Nairoukh, Z., Dalton, T., & Glorius, F. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201814471 · Cited by 326
The Zinc-Binding Group Effect: Lessons from Non-Hydroxamic Acid Vorinostat Analogs
Geurs, S., Clarisse, D., De Bosscher, K., & D’hooghe, M. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00226 · Cited by 58
Metadata
- Authors
- Ramesh, R., & Reddy, D. S.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2017-10-17
- Volume
- 61
- Issue
- 9
- Pages
- 3779-3798
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2766720996
- Cited by
- 624
- References
- 74
- FWCI
- 10.72
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.